Cargando…
Genome-wide epigenetic profiling of breast cancer tumors treated with aromatase inhibitors
Aromatase inhibitors (AI) are extensively used in the treatment of estrogen receptor-positive breast cancers, however resistance to AI treatment is commonly observed. Apart from Estrogen receptor (ERα) expression, no predictive biomarkers for response to AI treatment are clinically applied. Yet, sin...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536071/ https://www.ncbi.nlm.nih.gov/pubmed/26484094 http://dx.doi.org/10.1016/j.gdata.2014.06.023 |